P Jenkins, R Michelson, P A Emerson. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Azo Compounds/adverse effectsExcipientsFemaleGastrointestinal Diseases/chemically inducedHumansIsoniazid/administration & dosageMiddle AgedRifampin/administration & dosageTabletsTuberculosis/drug therapy
Substances: See more » Azo CompoundsExcipientsTablets6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium saltIsoniazidRifampin
Year: 1982 PMID: 6124784 DOI: 10.1016/s0140-6736(82)90575-x
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321